Table 1.
Comparing characteristics of COVID-19 AIS with non-COVID-19 AIS patients.
Fig 1.
Relation of COVID-19 pneumonia and LVO in COVID-19 AIS patients.
COVID-19 AIS patients with pneumonia more often had concomitant LVO (p = 0.139).
Fig 2.
Association between COVID-19 severity and functional outcome.
More severe COVID-19 infection resulted in worse functional outcomes (p = 0.01). Data are presented as mean ± SD, *p<0.05.
Table 2.
Comparing clinical characteristics of mild-moderate vs. severe-critical COVID-19 AIS patients.
Fig 3.
Summarizes the length of hospitalization and outcome result in COVID-19 AIS and non-COVID-19 AIS patients.
(A). The average length of hospitalization. A significant difference between treatment duration can be observed. Data are presented as mean ± SD.**p<0.01. (B). Functional state at discharge. Non-COVID-19 AIS patients showed significantly more favorable functional outcomes (mRS ≤2) than COVID-19 patients; p = 0.02 (C). In-hospital mortality rates. There is significantly higher mortality in COVID-19 AIS patients; p = 0.02.
Table 3.
Comparing characteristics of COVID-19 AIS with non-COVID-19 AIS patients in NIHSS range 5–15.